Molecular Analysis of Hepatitis B Virus in Mothers-Children Pairs

Special Issue - Hepatitis B

Austin J Infect Dis. 2021; 8(1): 1045.

Molecular Analysis of Hepatitis B Virus in Mothers-Children Pairs

Chatzidaki V1, Perdikogianni C1*, Paraskevis D2, Iliopoulos I3, Sourvinos G4, Kouroumalis E5 and Galanakis E1

1Department of Paediatrics, Medical School, University of Crete, Heraklion, Greece

2Department of Hygiene and Epidemiology, National and Kapodistrian University of Athens, Greece

3Laboratory of Bioinformatics, Department of Basic Sciences, Medical School University of Crete, Heraklion, Greece

4Laboratory of Clinical Virology, Medical School, University of Crete, Heraklion, Greece

5Department of Gastroenterology, Medical School, University of Crete, Heraklion, Greece

*Corresponding author: Perdikogianni C, Department of Paediatrics, University of Crete, 70013 Heraklion, Greece

Received: March 29, 2021; Accepted: April 24, 2021; Published: May 01, 2021

Abstract

Background: Vertical transmission of Hepatitis B Virus (HBV) is the primary infection source for infants, but little is known on the proportion of children that have acquired HBV from their mothers.

Objective: We investigated the relationship of HBV sequencing in HBVpositive children and their mothers and explored the HBV phylogenetic tree.

Methods: Serum-extracted HBV-DNA from 38 individuals (13 children paired to nine mothers, 16 unpaired infected children) was amplified by polymerase chain reaction and the target region HBV surface glycoprotein (amino acids 40-171) was directly sequenced. Following editing and alignment of these sequences, phylogenetic tree analysis was performed using the neighbourjoining and maximum-likelihood methods.

Results: Analysis was successfully performed in 29 subjects (23 children and six mothers), including six mother-child pairs. All individuals were infected by genotype D. Subgenotype adw3 prevailed (21, 72.4%), followed by ayw2 (4, 13.8%) and ayw3 (4, 13.8%). Among six mother-child pairs, three had identical and three had different subgenotypes. Phylogenetic analysis revealed that HBV sequences from three children did not cluster with their siblings suggesting a different source of infection.

Conclusion: Our findings suggest that HBV subgenotypes in infected children may not be identical to their mothers’ and point to non-vertical HBV transmission in childhood.

Keywords: Hepatitis B virus; Vertical transmission; Non-vertical transmission; Mothers; Children

Abbreviations

HBV: Hepatitis B Virus; HBsAg: Hepatitis B Surface Antigen; Hepatitis B e Antigen; anti HBe: Hepatitis B e antibody; PCR: Polymerase Chain Reaction

Introduction

Hepatitis B Virus (HBV) remains a considerable health problem despite global immunization strategies, with more than 250 million people having chronic liver infection worldwide [1]. Acquisition of infection in early life is associated with chronicity and mother to child transmission provides a reservoir for chronic carriers and increases the risk for cirrhosis and hepatocellular carcinoma. Vertical transmission of HBV seems to be a principal source of infection for infants, but little is known on the proportion of children that have acquired HBV from their mothers. Previous studies using comparison of HBV DNA sequences and phylogenetic analyses have shown that HBV of chronically infected children originates mainly from their mothers [2,3], but increasing evidence exists for horizontal intrafamiliar transmission [2,4]. The source of infection and other factors including viral genotype and subgenotypes may have an impact on the long-term clinical course of chronic HBV infection [3].

Greece is a country with low to moderate HBV endemicity (HBsAg carriage rates of 0.29-2.6 %) [5]. HBV prevalence is higher among populations with limited access to health care services, i.e., the moving Roma population and immigrants from the Balkans and East European countries [5]. The aim of this study was to explore the phylogenetic tree of pre-S/S HBV gene region in a high-risk moving and immigrant population group in a country of intermediate endemicity and to assess the molecular profile of HBV in HBV positive children and their mothers and hence the molecular closeness of HBV between mothers and children.

Subjects and Methods

Subjects

Samples from 38 individuals were analyzed in the study. Serum samples were obtained from 29 children and adolescents, aged five to 18 years (median age 12.7 years), with suboptimal immunoprophylaxis against HBV, positive for HBV since their early childhood and born to HBsAg positive mothers. Among 19 children with known HBeAg status, 14 were HBeAg positive and five were anti-HBe positive. Sera from nine mothers (13 pairs formed) were collected. None of the subjects had received antiviral treatment or suffered from other concomitant liver or immune disease. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. Informed consent was obtained from all the mothers and the older children prior to their enrolment and the study was approved by the institutional Ethical Committee, School of Medicine, University of Crete.

Methods

Serological tests: Commercially available enzyme-linked immune assay kits were used according to the manufacturer’s instructions to test serological markers of HBV infection.

Extraction of HBV DNA and determination of HBV subtype and genotype: HBV nucleic acid was extracted from 200μl of serum using a commercially available kit (QIAmp DNA Blood Mini Kit, Qiagen, Hilden, Germany) and were amplified by nested PCR using high fidelity DNA polymerase with proof reading activity and primers derived from the well-conserved areas in the S gene region of the HBV genomes of all eight genotypes (A to H) reported so far [6]. The firstround PCR (94°C for 2 min before the start of cycling: 94°C for 30sec, 55°C for 30sec, and 72°C for 90sec, with an additional 7min in the last cycle) was performed for 35 cycles with primers HB095 (sense, 5'-GAG TCT AGA CTC GTG GTG GAC-3') and HB184 (antisense, mixture of two sequences: 5'-CGA ACC ACT GAA CAA ATG GCA CCG C-3' and 5'-CGC ACC ACT GAA CAA ATT GCA C-3'). The second-round PCR for 25 cycles was carried out under the same conditions as the first-round PCR except for extension for 60 sec with primers HB097 (sense, 5'-GAC TCG TGG TGG ACT TCT CTC-3') and S2-2 (antisense, 5'-GGC ACT AGT AAA CTG AGC CA-3'). The amplification product of the first-round PCR was 461 base pairs (bp) (nucleotides (nt) 244 to 704), and that of the second-round PCR was 437bp (nt 251 to 687). Nucleotide numbers were in accordance with a genotype C HBV isolate of 3,215nt (AB033550). The PCR product was gel-purified and DNA fragments were sequenced with a sequencer ABI PRISMA® 3700 Genetic Analyzer.

Determination of HBV subgenotypes: The nucleotide sequences were translated into amino acid sequences according to the openreading frames of the partial S gene and the HBV subtypes were predicted from the amino acids (aa) at positions 122 (Lys/Arg for d/y determinants), 127 (Pro for w1-2, Thr for w3 and Ile for w4) and 160 (Lys for w and Arg for r). Discrimination between ayw1 and ayw2 was based on positions 134 and 159 (Phe and Ala, for ayw1 and Tyr and Gly for ayw2, respectively) [7].

HBV Genotypes Determination and Phylogenetic Analysis: HBV genotype was determined by sequence analysis of a 437 bp fragment from the HBV S gene fragment (primer sequences at both ends were excluded), using the genotyping tool available at the National Library of Medicine’s National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/projects/genotyping/ formpage.cgi) [8]. Sequence alignment was performed using Clustal W [9]. Phylogenetic analysis was carried out using approximatemaximum likelihood (ML) as implemented FastTree using the GTR+cat nucleotide substitution model. Analysis was done on the partial S gene sequences from 35 sequences obtained from the study subjects and all genotype D (N=2,965) sequences available on public database. Statistical robustness of the tree was assessed using the Shimodaira-Hasegawa (SH) values as implemented in FastTree. Phylogenetic trees were visualized using FigTree program. Moreover, phylogenetic analyses were performed on a set of sequences from the study population and the most similar ones identified by BLAST search (http://blast.ncbi.nlm.nih.gov/Blast.cgi).

Results

HBV genotypes and subgenotypes in the total cohort

All children and all mothers carried the HBV D genotype (Table 1). Subgenotype was identified in 29 subjects (23 children and six mothers). The analysis showed that adw3 was the most prevalent subgenotype detected in 21 out of 29 subjects (72.4%), followed by ayw2, detected in 4 (13.8%) and ayw3 (4, 13.8%). Direct sequencing was successfully performed in all 29 PCR-amplified samples and the phylogenetic tree is shown in Figure 1.

Citation: Chatzidaki V, Perdikogianni C, Paraskevis D, Iliopoulos I, Sourvinos G, Kouroumalis E, et al. Molecular Analysis of Hepatitis B Virus in Mothers-Children Pairs. Austin J Infect Dis. 2021; 8(1): 1045.